@morley
yes, that's a good point (regarding the discount rate used to value biological assets).
At the same time, I would be surprised that the market values ATP based on a P/B of 1 x, if they are able to keep their existing level of free cash flow.
If ATP is valued at its book value, it still corresponds to a free cash flow yield of around 29 %.
- Forums
- ASX - By Stock
- ATP
- Ann: 31 December 2021 Interim Financial Report
Ann: 31 December 2021 Interim Financial Report, page-24
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATP (ASX) to my watchlist
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.96M |
Open | High | Low | Value | Volume |
13.0¢ | 14.0¢ | 13.0¢ | $29.79K | 218.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17005 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 196994 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17005 | 0.135 |
12 | 332693 | 0.130 |
4 | 395000 | 0.125 |
6 | 406674 | 0.120 |
2 | 443482 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 196994 | 6 |
0.145 | 249814 | 4 |
0.150 | 338697 | 5 |
0.155 | 112516 | 2 |
0.160 | 187626 | 3 |
Last trade - 15.19pm 06/09/2024 (20 minute delay) ? |
Featured News
ATP (ASX) Chart |